Quarterly report pursuant to Section 13 or 15(d)

NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.7.0.1
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Dec. 31, 2016
Accounting Policies [Abstract]          
Research and Development Expense $ 1,339,039 $ 1,153,043 $ 2,677,643 $ 1,579,157  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 8,245,190   8,245,190   8,245,190
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number 7,273,218   7,273,218   7,028,639